SavedAdd your journal

Journals / Turkish Journal of Anaesthesiology and Reanimation / 2021 / Cilt: 49 - Sayı: 6

Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19- Associated Severe Acute Respiratory Distress Syndrome

Verda TUNA
Perihan ERGİN ÖZCAN
Emre ÇELİKSOY
Özlem POLAT
İlkay ANAKLI
Günseli ORHUN
Gülçin ALAY
Figen ESEN
Pages
480–483
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic compli- cations leading to mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypercoagulopathy associated with the novel coronavirus disease (COVID-19) is the leading cause of acute respiratory distress syndrome (ARDS), multiple organ failure, and mortality.
📊
Key Findings & Data:Extracorporeal membrane oxygenation (ECMO) has been used to manage patients with COVID 19-associated severe respiratory or cardiac failure.
💡
Conclusion & Impact:Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic compli- cations leading to mortality.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

Hypercoagulopathy associated with the novel coronavirus disease (COVID-19) is the leading cause of acute respiratory distress syndrome (ARDS), multiple organ failure, and mortality. Extracorporeal membrane oxygenation (ECMO) has been used to manage patients with COVID 19-associated severe respiratory or cardiac failure. In this report, we aim to summarise our experience with deadly thrombotic complications during venovenous ECMO (vvECMO) treatment in 6 patients with COVID-19-associated ARDS between March 19, 2020 and April 20, 2020. Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic compli- cations leading to mortality.

🔖

Cite This Article

TUNA, V., ÖZCAN, P. E., ÇELİKSOY, E., POLAT, Ö., ANAKLI, İ., ORHUN, G., ALAY, G., ESEN, F. (2021). Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19- Associated Severe Acute Respiratory Distress Syndrome. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 49 - Sayı: 6, 480–483. https://ajindex.com/articles/403427

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Frantzeskaki F, Armaganidis A, Orfanos SE. Immuno throm- bosis in Acute Respiratory Distress Syndrome: Cross Talks be- tween Inflammation and Coagulation. Respiration. 2017
  2. [Crossref] 2. Ogino Mark T. Extracorporeal Life Support Organization COVID-19 Interim Guidelines. ELSO. Accessed April, 16 2020. https://www.elso.org. 3. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. WHO. Accessed February 20, 2020. https://www.who.int/publica- tions/i/item/10665-332299 4. Beyls C, Huette P, Abou-Arab O, Berna P, Mahjoub Y. ECMO for COVID-19 associated severe ARDS and risk of thrombosis. Br J Anaesth. 2020
  3. E260-262. 5. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020
  4. [Crossref] 6. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020
  5. [Crossref] 7. Salerno M, Sessa F, Piscopo A, et al. No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science. J Clin Med. 2020
  6. [Crossref] 8. Rokkam VRP, Vegunta R, Prudhvi K, et al. “Weighing” the risks and benefits-Thromboprophylaxis challenges in obese COVID-19 patients. Obes Med. 2020
  7. 100284. [Crossref] 9. Silvio A. ECMO for ARDS due to COVID-19. Heart Lung. 2020
  8. [Crossref] 10. Kowalewski M, Fina D, Słomka A, et al. COVID-19 and ECMO: the interplay between coagulation and inflammation a narrative review. Critical Care. 2020
  9. [Crossref] 11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation param- eters are associated with poor prognosis in patients with novel corona virus pneumonia. J Thromb Haemost. 2020
  10. [Crossref] 12. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in criticallyill ICU patientswith COVID-19. Thromb Res. 2020
  11. [Crossref] 13. Parzy G, Daviet F, Puech B, et al. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Ox- ygenation for Severe Acute Respiratory Syndrome Corona- virus 2 Based on CT Scans. Crit Care Med. 2020
  12. e971-975. [Crossref] 14. Pons S, Fodil S, Azoulay E, Zafranil L. The vascular endothe- lium: The corner stone of organ dysfunction in severe SARS- CoV-2 infection. Crit Care. 2020
  13. [Crossref] 15. Arachchillage DJ, Remmington C, Rosenberg A, et al. Ant